BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 18789069)

  • 1. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
    Choi CW; Park HS; Kim YK; Lee SH; Cho KH
    J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
    Arits AH; Van Marion AM; Lohman BG; Thissen MR; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Eur J Dermatol; 2011; 21(6):870-3. PubMed ID: 21865121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?
    Katona TM; Perkins SM; Billings SD
    J Cutan Pathol; 2008 Feb; 35(2):174-9. PubMed ID: 18190441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
    Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
    Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
    Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
    Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
    Evangelista MT; North JP
    J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
    Sellheyer K; Krahl D
    Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panel vs. single marker for discriminating desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma.
    Vollmer RT
    J Cutan Pathol; 2009 Feb; 36(2):283; author reply 284. PubMed ID: 19208081
    [No Abstract]   [Full Text] [Related]  

  • 10. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma.
    Kirchmann TT; Prieto VG; Smoller BR
    Arch Dermatol; 1994 May; 130(5):589-92. PubMed ID: 7513986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichoepithelioma with an adjacent basal cell carcinoma, transformation or collision?
    Wallace ML; Smoller BR
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):343-5. PubMed ID: 9270544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
    Sellheyer K; Nelson P; Kutzner H; Patel RM
    J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
    Sellheyer K; Nelson P
    J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of solitary trichoepithelioma versus basal cell carcinoma.
    Votruba M; Collins CM; Harrad RA
    Eye (Lond); 1998; 12 ( Pt 1)():43-6. PubMed ID: 9614515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of basal cell carcinoma from trichoepithelioma by lectin histochemistry.
    Haneke E
    Br J Dermatol; 1995 Jun; 132(6):1024-5. PubMed ID: 7662561
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation.
    Costache M; Bresch M; Böer A
    Histopathology; 2008 Jun; 52(7):865-76. PubMed ID: 18462369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
    Yu L; Galan A; McNiff JM
    J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichoepithelioma: a 19-year clinicopathologic re-evaluation.
    Bettencourt MS; Prieto VG; Shea CR
    J Cutan Pathol; 1999 Sep; 26(8):398-404. PubMed ID: 10551412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.